InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,345.17
(
0.16%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: DewDiligence post# 214545

Tuesday, 10/24/2017 12:47:07 PM

Tuesday, October 24, 2017 12:47:07 PM

Post# of 252302
thx. I find it curious that the FDA cleared the MR system (Perspectum) for early liver disease imaging with minimal biopsy supporting data. That's the implication because the trial to collect biopsy data to support imaging results is not to be completed for another 3 years. There had to be some biopsy data?

https://clinicaltrials.gov/ct2/show/NCT03165201
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up